Resting heart rate and the incidence and progression of valvular calcium: The Multi-Ethnic Study of Atherosclerosis (MESA)
- PMID: 29677630
- PMCID: PMC5949274
- DOI: 10.1016/j.atherosclerosis.2018.04.004
Resting heart rate and the incidence and progression of valvular calcium: The Multi-Ethnic Study of Atherosclerosis (MESA)
Abstract
Background and aims: Left-sided valvular calcification is associated with cardiovascular disease (CVD) morbidity and mortality. Resting heart rate (RHR) may influence valvular calcium progression through shear stress. Whether RHR, an established CVD risk factor, is associated with valvular calcium progression is unknown. We assessed whether RHR predicts incidence and progression of mitral annular calcium (MAC) and aortic valve calcium (AVC) in a community-based cohort free of CVD at baseline.
Methods: RHR was obtained from baseline electrocardiograms of 5498 MESA participants. MAC and AVC were quantified using Agatston scoring from cardiac computed tomography scans obtained at baseline and at a second examination during follow-up. We examined associations of RHR with incident MAC/AVC and annual change in MAC/AVC scores, after adjusting for demographics, CVD risk factors, physical activity, and atrioventricular nodal blocker use.
Results: At baseline, participants had mean age of 62 ± 10 years and mean RHR of 63 ± 10 bpm; 12.3% and 8.9% had prevalent AVC and MAC, respectively. Over a median of 2.3 years, 4.1% and 4.5% developed incident AVC and MAC, respectively. Each 10 bpm higher RHR was significantly associated with incident MAC [Risk Ratio 1.17 (95% CI 1.03-1.34)], but not incident AVC. However, RHR was associated with AVC progression [β = 1.62 (0.45-2.80) Agatston units/year for every 10 bpm increment], but not MAC progression.
Conclusions: Higher RHR was associated with MAC incidence and AVC progression, independent of traditional CVD risk factors. Future studies are needed to determine whether modification of RHR through lifestyle or pharmacologic interventions can reduce valvular calcium incidence or progression.
Keywords: Aortic valve calcium; Cardiovascular; Computed tomography; Mitral annular calcium; Progression; Resting heart rate.
Copyright © 2018 Elsevier B.V. All rights reserved.
Conflict of interest statement
Dr. Michos has received an honorarium from Siemens Healthcare Diagnostics (unrelated to this topic). Dr. Budoff has received research funds from GE Healthcare. No other authors declare a conflict of interest.
Figures
Similar articles
-
Exposure to ambient air pollution and calcification of the mitral annulus and aortic valve: the multi-ethnic study of atherosclerosis (MESA).Environ Health. 2017 Dec 21;16(1):133. doi: 10.1186/s12940-017-0346-x. Environ Health. 2017. PMID: 29268751 Free PMC article.
-
Relation of Serum Vitamin D to Risk of Mitral Annular and Aortic Valve Calcium (from the Multi-Ethnic Study of Atherosclerosis).Am J Cardiol. 2017 Aug 1;120(3):473-478. doi: 10.1016/j.amjcard.2017.05.004. Epub 2017 May 11. Am J Cardiol. 2017. PMID: 28583687 Free PMC article.
-
Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis.Atherosclerosis. 2019 Jun;285:79-86. doi: 10.1016/j.atherosclerosis.2019.04.215. Epub 2019 Apr 13. Atherosclerosis. 2019. PMID: 31048102 Free PMC article.
-
Associations of LV hypertrophy with prevalent and incident valve calcification: Multi-Ethnic Study of Atherosclerosis.JACC Cardiovasc Imaging. 2012 Aug;5(8):781-8. doi: 10.1016/j.jcmg.2011.12.025. JACC Cardiovasc Imaging. 2012. PMID: 22897991 Free PMC article.
-
Valvular and perivalvular abnormalities in end-stage renal disease.Am J Med Sci. 2003 Apr;325(4):237-42. doi: 10.1097/00000441-200304000-00010. Am J Med Sci. 2003. PMID: 12695729 Review.
Cited by
-
Aortic Valve Calcium Score: Applications in Clinical Practice and Scientific Research-A Narrative Review.J Clin Med. 2024 Jul 11;13(14):4064. doi: 10.3390/jcm13144064. J Clin Med. 2024. PMID: 39064103 Free PMC article. Review.
-
Differences in TAVR Utilization in Aortic Stenosis Among Patients With and Without Psychiatric Comorbidities.J Soc Cardiovasc Angiogr Interv. 2024 Aug 13;3(9):102235. doi: 10.1016/j.jscai.2024.102235. eCollection 2024 Sep. J Soc Cardiovasc Angiogr Interv. 2024. PMID: 39575218 Free PMC article.
-
Ideal cardiovascular health and resting heart rate in the Multi-Ethnic Study of Atherosclerosis.Prev Med. 2020 Jan;130:105890. doi: 10.1016/j.ypmed.2019.105890. Epub 2019 Nov 9. Prev Med. 2020. PMID: 31715219 Free PMC article.
-
The association of resting heart rate with the development and progression of aortic stenosis.Eur Heart J Cardiovasc Imaging. 2023 Oct 27;24(11):1566-1567. doi: 10.1093/ehjci/jead204. Eur Heart J Cardiovasc Imaging. 2023. PMID: 37589172 Free PMC article. No abstract available.
-
The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis.Atherosclerosis. 2019 Mar;282:91-99. doi: 10.1016/j.atherosclerosis.2019.01.011. Epub 2019 Jan 24. Atherosclerosis. 2019. PMID: 30716566 Free PMC article.
References
-
- Kizer JR, Wiebers DO, Whisnant JP, et al. Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study. Stroke. 2005;36:2533–2537. - PubMed
-
- Fox CS, Vasan RS, Parise H, et al. Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study. Circulation. 2003;107:1492–1496. - PubMed
-
- Paulsen NH, Carlsen BB, Dahl JS, et al. Association between aortic valve calcification measured on non-contrast computed tomography and aortic valve stenosis in the general population. J Cardiovasc Comput Tomogr. 2016;10:309–315. - PubMed
-
- Messika-Zeitoun D, Bielak LF, Peyser PA, et al. Aortic valve calcification: determinants and progression in the population. Arterioscler Thromb Vasc Biol. 2007;27:642–648. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
- R01 HL071739/HL/NHLBI NIH HHS/United States
- N01HC95160/HL/NHLBI NIH HHS/United States
- N01HC95163/HL/NHLBI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- N01HC95169/HL/NHLBI NIH HHS/United States
- N01HC95164/HL/NHLBI NIH HHS/United States
- N01HC95162/HL/NHLBI NIH HHS/United States
- N01HC95165/HL/NHLBI NIH HHS/United States
- N01HC95159/HL/NHLBI NIH HHS/United States
- N01HC95167/HL/NHLBI NIH HHS/United States
- N01HC95166/HL/NHLBI NIH HHS/United States
- N01 HC095162/HC/NHLBI NIH HHS/United States
- N01HC95168/HL/NHLBI NIH HHS/United States
- F32 HL134290/HL/NHLBI NIH HHS/United States
- N01HC95161/HL/NHLBI NIH HHS/United States
- UL1 TR001420/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources